re: Ann: FDA approves Cochlear Nucleus Hybrid... Here is an interesting comment from Motley Fool:
Foolish takeaway
Cochlear was the most-shorted individual stock on the ASX as at 14 March 2014, followed by News Corp (ASX: NWS), UGL Limited (ASX: UGL) and Monadelphous Group (ASX: MND). With Cochlear shares up 2.5% at lunchtime today, many of those shorters may well be forced to cover their positions in the days, weeks and months ahead. I certainly wouldn’t want to be standing in front of the Cochlear train at this point in time.
- Forums
- ASX - By Stock
- COH
- Ann: FDA approves Cochlear Nucleus Hybrid for sal
COH
cochlear limited
Add to My Watchlist
0.51%
!
$318.52

Ann: FDA approves Cochlear Nucleus Hybrid for sal, page-4
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$318.52 |
Change
1.630(0.51%) |
Mkt cap ! $20.83B |
Open | High | Low | Value | Volume |
$318.03 | $319.10 | $314.87 | $40.27M | 126.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3 | $318.52 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$319.80 | 766 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3 | 318.520 |
1 | 72 | 317.810 |
1 | 72 | 317.380 |
1 | 92 | 315.000 |
1 | 56 | 314.500 |
Price($) | Vol. | No. |
---|---|---|
319.800 | 60 | 1 |
319.890 | 65 | 1 |
320.000 | 1100 | 15 |
320.560 | 466 | 1 |
320.770 | 50 | 1 |
Last trade - 16.10pm 31/07/2025 (20 minute delay) ? |
Featured News
COH (ASX) Chart |